Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase

Nature Medicine
P M GrobJ Adams

Abstract

Chimpanzees were challenged with HIV-1IIIB while receiving a short regimen of nevirapine (Viramune), a nonnucleoside inhibitor of HIV-1 reverse transcriptase. The untreated, control chimpanzee developed an infection characterized by seroconversion, viremia in peripheral blood mononuclear cells (PBMCs), and plasma positive for viral RNA. In contrast, the three nevirapine-treated chimpanzees remained negative for all viral markers with the exception of nested polymerase chain reaction (PCR) analysis of PBMCs for viral DNA. Although PBMCs from the three nevirapine-treated chimpanzees tested intermittently positive for viral DNA, this PCR signal disappeared and remained negative for the final five months of the study. These data indicate that orally administered nevirapine provided protection from HIV-1 infection in the chimpanzee model.

References

Dec 1, 1991·AIDS Research and Human Retroviruses·A M PrinceJ W Eichberg
Jan 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M GirardE Muchmore
Dec 14, 1989·The New England Journal of Medicine·D D HoM Alam
Feb 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·S H CheesemanM Myers
Apr 1, 1995·Trends in Biotechnology·A D Lewis, P R Johnson
Apr 1, 1993·AIDS Research and Human Retroviruses·B K JohnsonC J Gibbs
Feb 1, 1993·Antimicrobial Agents and Chemotherapy·S H CheesemanJ J Keirns

❮ Previous
Next ❯

Citations

Nov 27, 2001·Bioorganic & Medicinal Chemistry Letters·Y M ZhuK H Lee
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·I C SunK H Lee
Nov 1, 2007·Journal of Applied Animal Welfare Science : JAAWS·Andrew Knight
Sep 10, 2011·AIDS Research and Human Retroviruses·Koen K A Van Rompay
Jun 18, 2010·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de Expertos de Gesida, UNKNOWN Plan Nacional sobre el Sida
Jul 23, 2009·Antiviral Research·Koen K A Van Rompay
Mar 25, 2006·Expert Opinion on Pharmacotherapy·James A McIntyre
Apr 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Dominique ReyYolande Obadia
Apr 20, 2002·Current Opinion in Infectious Diseases·David A. Hawkins
Dec 14, 2002·AIDS·Oriol CollPier-Angelo Tovo
Jun 5, 2003·Pediatrics·Peter L Havens, UNKNOWN American Academy of Pediatrics Committee on Pediatric AIDS

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Infectious Disease Reports
Joanne Stekler, A C Collier
Journal of Acquired Immune Deficiency Syndromes : JAIDS
C A SabinI Williams
Journal of Acquired Immune Deficiency Syndromes : JAIDS
W J FesselT P Young
AIDS Research and Human Retroviruses
Mayte Pérez-OlmedaHCV/HIV Spanish Study Group
© 2021 Meta ULC. All rights reserved